Related Experiment Video
Updated: May 10, 2025

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Hypidone Hydrochloride (YL-0919), a Sigma-1 Receptor Agonist, Improves Attention by Increasing BDNF in mPFC
Yixin Yang1, Yue Zhang2, Xiaojuan Hou3
1Beijing Institute of Basic Medical Sciences, Beijing 100000, China.
Abstract:
Background/Objectives: The available treatment for attention deficit is drug therapy, but the drugs show poor adverse effect profiles and individual variability in response, especially in adults. Hypidone hydrochloride (YL-0919) is a selective sigma-1 receptor agonist that demonstrated a faster onset antidepressant effect in our previous studies. Current studies aim to study the attention-enhancing effect and mechanism of YL-0919. Methods: We used the five-choice serial reaction time task (5-CSRTT) to measure the attention-improving effect of YL-0919 in SD rats under a physiological state and exogenous corticosterone (CORT)-exposed state. The depression/anxiety-like behavioral experiments were used in the CORT-exposed rats. Immunofluorescence staining, western blotting, and Golgi-Cox staining were used to investigate the attention-improving mechanism of YL-0919. Results: The studies found that intragastric administration of 2.5 and 5 mg/kg YL-0919 for 6 days significantly improved the attention of SD rats under a physiological state. CORT exposure caused depression/anxiety-like behaviors and attention deficit in the rats. Intragastric administration of 3 mg/kg SA4503 or 2.5 and 5 mg/kg YL-0919 for 6 days significantly alleviated attention deficit in SD rats under an exogenous CORT-exposed state. In addition, YL-0919 administration obviously increased the expression of BDNF, PSD95, and synapsin1 and improved the dendritic complexity and the dendritic spine density in the medial prefrontal cortex (mPFC). Conclusions: These results reveal that YL-0919 as a selective sigma-1 receptor agonist can significantly improve the attention of SD rats under a physiological state and exogenous CORT-exposed state. Improving the level of BDNF and dendritic complexity in the mPFC may be the important mechanisms of YL-0919 to improve attention. The study also provides a potential novel target for the drug therapy of attention deficit.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Drugs Affecting Neurotransmitter Synthesis

